Dermal Fillers and Botulinum Toxin Market: Hyaluronic Acid Based Dermal Fillers Projected to be the Second Most Lucrative Segment by Product Type: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027

  • Published: 2017-08-24
  • Report Code: REP-GB-4733

An Incisive, In-depth Analysis on the Dermal Fillers And Botulinum Toxin Market

This study offers a comprehensive, 360 degree analysis on the Dermal Fillers And Botulinum Toxin market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Dermal Fillers And Botulinum Toxin market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Celebrity endorsements and consumer market are an important growth driver

Several dermatology association members i.e. service providers and clinics have seen an increased uptake of aesthetic procedures in the year 2016. The American Academy of Facial Plastic and Reconstructive Surgery estimates that more than 80% of surgeons believed a celebrity endorsement played a vital role in the patient being willing to go under the knife and undergo treatment. The most common procedures are the application of botilinum toxin leading to wrinkle reduction by way of volume restoration. Social and mainstream media have also had an outsized impact on the customer psyche, influencing them to start these treatments early to avoid the onset of ageing or delay it as much as possible.

Rising preference for non-invasive surgical procedures across the globe

The demand for minimally invasive cosmetic treatment, a phenomenon seen worldwide, is poised to benefit the Dermal Fillers and Botulinum Toxin Market. Dermatologists prefer to treat skin diseases through less invasive procedures or topical applications in place of surgical methods. The non-surgical procedures that witnessed a dramatic spike in popularity in 2016 were dermal fillers with hyaluronic acid and botulinum toxin. Injectable treatments are chosen because of greater awareness of measurable improvement in procedures and more information dissemination.

Hyaluronic Acid and Botulinum Toxin key in dermal fillers and botulinum toxin market

Botulinum Toxin is the largest segment in the Dermal Fillers and Botulinum Toxin Market by product type and is larger than the other two segments combined. It is expected to push past US$ 5 Bn by the end of the forecast period making it imperative for key stakeholders in the Dermal Fillers and Botulinum Toxin Market to target. However, the Hyaluronic Acid segment is anticipated to witness a high CAGR of 8.5% from 2017-2027, which companies would do well to take note of while devising their Hyaluronic Acid Dermal Fillers and Botulinum Toxin Market strategies.The Botulinum Toxin segment dominated the global Dermal Fillers and Botulinum Toxin market by product type in terms of revenue in 2017, and this trend is projected to continue throughout the forecast period. Botulinum Toxin is the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.

dermal fillers and botulinum toxin market

Inadequate professional training serious concern in the dermal fillers and botulinum toxin market

The treatments are sometimes administered incorrectly to patients and this can lead to serious complications with extremely adverse side-effects. Fillers are injected around the temple region of the head to even out fine lines and reduce crow’s feet. Patients could experience symptoms such as swelling, fever, and extreme pain within two days, especially if the injection punctures a facial vein during the process of administration. These unfortunate accidents would need patients to be administered a dose of antibiotics or steroids that have their own additional side-effects. At present, a limited number of medical institutions offer the required advanced training and this is a particular problem in resource-starved, poorer countries in the world where such treatments are more of a luxury only enjoyed by the privileged few.

High cost a major restraint in the dermal fillers and botulinum toxin market

The cost of botolinum toxin treatments is on the higher side and multiple sessions are necessary to achieve the desired results. The surgeon or physician cost alone is approximately half the cost in the case of dermal fillers; and fillers such as HA, PLLA, CaHA last for a maximum period of two years. Most of them are naturally occurring in the body and they get degraded quickly, which is why multiple sessions are needed, thereby driving up the cost of treatment substantially. Frequent visits to the surgeon or physician is the norm that could potentially stifle the growth prospects of the global Dermal Fillers and Botulinum Toxin Market.

Report Introduction

Customers worldwide are increasingly opting for aesthetic procedures and treatments to look younger than their age suggests. The proliferation of qualified plastic surgeons and their well-established networks play a major role in the dermal fillers and botulinum toxin market. Future Market Insights has released a new report titled ‘Dermal Fillers and Botulinum Toxin Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027’ that is an exhaustive analysis of the dermal fillers and botulinum toxin market on the basis of key parameters such as Y-o-Y growth, CAGR, and absolute dollar opportunity.

The global dermal fillers and botulinum toxin market has been studied on the basis of seven key geographic regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The dermal fillers and botulinum toxin market report devotes an equal amount of attention to both developed and emerging regions by focussing on the drivers, restraints, opportunities and threats that exist in the regional dermal fillers and botulinum toxin market. The historical market size of the largest countries in every region has been compared and contrasted with the anticipated future growth so that key stakeholders in the dermal fillers and botulinum toxin market can gain a clear understanding. The market attractiveness analysis on the basis of the taxonomy concludes this section of the dermal fillers and botulinum toxin market report.

The dermal fillers and botulinum toxin market report begins with the executive summary that is concise and comprehensive. The section includes an overview comprising macroeconomic factors, important facts, and the revenue share by both product type and application. Our experts have analysed the dermal fillers and botulinum toxin market extensively and made their recommendations that you would be highly recommended to take into consideration while devising your long-term market strategies. The recommendations take the form of an overall market approach, segment and region to target with a differentiating strategy to race past your competition in the dermal fillers and botulinum toxin market.

The dermal fillers and botulinum toxin market introduction chapter follows the executive summary and should ideally be read in tandem with it. This section gives readers a grassroots level understanding of the dermal fillers and botulinum toxin market by way of the definition as well as the taxonomy of the dermal fillers and botulinum toxin market.

Dermal Fillers and Botulinum Toxin Market: Taxonomy

Region

Application

Product

Type

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • MEA

  • Aesthetic Volume Restoration

  • Wrinkle Reduction

  • Hyaluronic Acid Based Fillers

  • Non-Hyaluronic Acid Based Fillers

  • Botulinum Toxin

The pressure to look younger and fitter has never been more acute than in the 21st century. Key players actively involved in the dermal fillers and botulinum toxin market are more than willing to cater to this demand and are offering a diverse suite of products and services. As a new entrant seeking to enter the dermal fillers and botulinum toxin market or an incumbent who wishes to change your go-to- market strategy, you would do well to understand what your immediate rivals are planning in the dermal fillers and botulinum toxin market. The competition dashboard features some of the companies operating in the dermal fillers and botulinum toxin market by highlighting the key financials, revenue growth, operating and net margin, key ratios, and industry classification codes. A SWOT analysis, recent developments and a broad company strategy outline are highlighted in this section.

Research Methodology

The research methodology adopted by Future Market Insights is considered to be a benchmark in the industry. Our team of diverse and knowledgeable experts have years of experience and they put this to good use during their primary and secondary research in the dermal fillers and botulinum toxin market. They prepare a questionnaire that enables them to gather all the relevant information pertaining to the dermal fillers and botulinum toxin market. The facts are thoroughly scrutinised with the help of the triangulation method and the report data is finally validated using advanced company tools to deliver the required insights pertaining to the dermal fillers and botulinum toxin market. 

Dermal Fillers And Botulinum Toxin Market Reports - Table of Contents

Dermal Fillers And Botulinum Toxin Market Reports - List of Tables

Table 01: Global Dermal Fillers and Botulinum Toxin Market – Global FDA Dermal Fillers

Table 02: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 03: North America Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 04: North America Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 05: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 06: North America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 07: North America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 08: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 09: Latin America Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 10: Latin America Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 11: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 12: Latin America Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 13: Latin America Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 14: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 15: Western Europe  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 16: Western Europe  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 17: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 18: Western Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 19: Western Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 20: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 21: Eastern Europe  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 22: Eastern Europe  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 23: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 24: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 25: Eastern Europe Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 26: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 27: APEJ  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 28: APEJ  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 29: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 30: APEJ  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 31: APEJ Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 32: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 33: Japan  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 34: Japan  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 35: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 36: Japan  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 37: Japan Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 38: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 39: MEA  Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 40: MEA  Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 41: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Table 42: MEA  Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 43: MEA Dermal Fillers and Botulinum Toxin Participants Presence (Intensity Mapping)

Table 44 Global Dermal Fillers and Botulinum Toxin Market: Intensity Mapping by Company

Table 45 Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 46 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 47 Global Dermal Fillers Market Volume (1 ml vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 48 Global Botulinum Toxin Market Volume (100 unit vial)  Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 49 Global Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Application

Dermal Fillers And Botulinum Toxin Market Reports - List of Figures

Figure 01: U.S FDA Regulatory Approval for Medical Devices

Figure 02: Europe Regulatory Approval for Medical Devices

Figure 03: U.S. FDA approved Dermal Fillers

Figure 04: North America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 06: North America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 05: North America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 07: North America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 08: North America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 09: North America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 10: U.S. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 11: U.S. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 12: Canada Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 13: Canada Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 14: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 15: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 16: North America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027

Figure 17: North America - Drivers & Restrains Impact Analysis

Figure 18: Latin America Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 19: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 20: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 21: Latin America Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 22: Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 23: Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 24: Brazil  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 25: Brazil Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 26: Mexico Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 27: Mexico Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 28: Argentina Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 29: Argentina Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 30: Rest of Latin America Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 31: Rest of Latin America Dermal Fillers and Botulinum Toxin Market Forecast, 2012 - 2016

Figure 32: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 33: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 34: Latin America Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Country, 2017-2027

Figure 35: Latin America - Drivers & Restraint Impact Analysis

Figure 36: Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 37: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 38: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 39: Western Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 40: Western Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 41: Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 42: U.K. Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 43: U.K. Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 44: Germany Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 45: Germany Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 46: France Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 47: France Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 48: Italy Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 49: Italy Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 50: Spain Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 51: Spain Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 52: Nordics Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 53: Nordics Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 54: Benelux Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 55: Benelux Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 56: Rest of Western Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 57: Rest of Western Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 58: Western Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 59: Western Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 60: Western Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 61: Western Europe - Drivers & Restraint Impact Analysis

Figure 62: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 63: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 64: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 65: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 66: Eastern Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 67: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 68: Russia Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 69: Russia Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 70: Poland Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 71: Poland Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 72: Rest of Eastern Europe  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 73: Rest of Eastern Europe  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 74: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 75: Eastern Europe  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 76: Eastern Europe Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 77: Eastern Europe - Drivers & Restraint Impact Analysis

Figure 78: APEJ  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 79: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 80: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 81: APEJ  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 82: APEJ  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 83: APEJ  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 84: China Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 85: China Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 86: India Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 87: India Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 88: Australia and NZ Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 89: Australia and NZ Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 90: ASEAN Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 91: ASEAN Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 92: Rest of APEJ  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 93: Rest of APEJ  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 94: APEJ  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 95: APEJ  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 96: APEJ Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 97: APEJ - Drivers & Restraint Impact Analysis

Figure 98: Japan  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 99: Figure Japan  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 100: Japan  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 101: Japan  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 102: Japan  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 103: Japan  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 104: Japan  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 105: Japan- Drivers & Restraint Impact Analysis

Figure 106: MEA  Dermal Fillers and Botulinum Toxin Market Forecast 2017 and 2027

Figure 108: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Application (2017)

Figure 107: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Product Type (2017)

Figure 109: MEA  Dermal Fillers and Botulinum Toxin Market Value Share By Country (2017)

Figure 110: MEA  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 111: MEA  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 112: South Africa Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 113: South Africa Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 114: GCC Countries Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 115: GCC Countries Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 116: Rest of MEA  Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 117: Rest of MEA  Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 118: MEA  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 119: MEA  Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 120: MEA Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 121: MEA Drivers & Restraint Impact Analysis

Figure 122 : Dermal Fillers and Botulinum Toxin Market Forecast Factors – Relevance and Impact

Figure 123: Global Dermal Fillers and Botulinum Toxin Market Share Analysis

Figure 124: Global Dermal Fillers Market Share Analysis

Figure 125: Global Botulinum Toxin Market Share Analysis

Figure 126: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Region, 2017 & 2027

Figure 127: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Region, 2017-2027

Figure 128: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Product Type, 2017 & 2027

Figure 129: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Product Type, 2017-2027

Figure 130: Global Bone Dermal Fillers and Botulinum Toxin Market Value (US$ Mn) By Application, 2017 & 2027

Figure 131: Global Dermal Fillers and Botulinum Toxin Market Attractive Analysis By Application, 2017-2027

Figure 132: Global Dermal Fillers and Botulinum Toxin Historical Market Analysis 2012 - 2016

Figure 133: Global Dermal Fillers and Botulinum Toxin Market Forecast, 2017 - 2027

Figure 134: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2012 - 2016

Figure 135: Global Dermal Fillers and Botulinum Toxin Market Absolute $ Opportunity, 2017 - 2027

Figure 136:  Global Dermal Fillers and Botulinum Toxin Market - Value Chain

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology